Global Health, 543654, MEDANTA Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

30,318.32
64.62
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

29,523.87
0.04%
9.19

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.61
16.90
14.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.90
33.38
12.05

PAT CAGR (%)

10 Years
5 Years
3 Years

12.51
67.42
34.58

P:E (Median)

8 Years
5 Years
3 Years

-
-
63.11

P:BV (Average)

8 Years
5 Years
3 Years

-
-
8.86

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
31.96

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 17.8 17.92 23.39 28.56
P/E Ratio 65.19 64.75 49.61 40.63
Revenue 3275 3692 4301 5002
EBITDA 799 877 1039 1256
Net Income 478 481 625 767
ROA 11.4 10.6 11.2 11.4
P/B Ratio 10.94 9.20 7.79 6.56
ROE 17.93 15.3 16.8 17.32
FCFF 337 121 131 244
FCFF Yield 1.05 0.38 0.41 0.76
Net Debt -373 -405 -740 -761
BVPS 106.1 126.08 149.04 176.83

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 802.87 578.64 38.75% 624.40 561.68 11.17% 664.61 580.15 14.56% 611.45 544.59 12.28%
Expenses 607.67 456.43 33.14% 484.88 439.15 10.41% 514.30 451.84 13.82% 479.15 435.24 10.09%
EBITDA 195.20 122.22 59.71% 139.52 122.53 13.87% 150.31 128.30 17.16% 132.30 109.34 21.00%
EBIDTM 24.31% 21.12% 22.35% 21.81% 22.62% 22.12% 21.64% 20.08%
Other Income 25.67 32.55 -21.14% 22.17 25.83 -14.17% 23.58 26.24 -10.14% 26.70 33.20 -19.58%
Interest 7.10 6.21 14.33% 5.94 5.76 3.12% 5.37 6.11 -12.11% 5.95 6.38 -6.74%
Depreciation 37.98 23.39 62.38% 23.44 21.73 7.87% 24.91 21.54 15.65% 23.30 20.43 14.05%
PBT 125.89 125.17 0.58% 132.31 120.87 9.46% 143.61 126.89 13.18% 129.74 115.74 12.10%
Tax 32.48 32.93 -1.37% 33.01 33.53 -1.55% 39.14 31.80 23.08% 33.46 29.53 13.31%
PAT 93.41 92.24 1.27% 99.30 87.34 13.69% 104.47 95.10 9.85% 96.28 86.21 11.68%
PATM 11.63% 15.94% 15.90% 15.55% 15.72% 16.39% 15.75% 15.83%
EPS 3.48 3.43 1.46% 3.70 3.25 13.85% 3.89 3.54 9.89% 3.58 3.21 11.53%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 931.25 808.63 15.16% 943.44 832.60 13.31% 956.55 843.94 13.34% 861.08 773.04 11.39%
Expenses 706.56 629.28 12.28% 705.67 620.51 13.72% 728.27 631.09 15.40% 674.75 595.16 13.37%
EBITDA 224.69 179.35 25.28% 237.76 212.09 12.10% 228.29 212.85 7.25% 186.32 177.88 4.74%
EBIDTM 24.13% 22.18% 25.20% 25.47% 23.87% 25.22% 21.64% 23.01%
Other Income 22.93 27.42 -16.37% 16.02 21.93 -26.95% 18.22 20.75 -12.19% 21.93 21.46 2.19%
Interest 15.03 18.23 -17.55% 16.27 17.68 -7.98% 15.97 20.09 -20.51% 17.98 17.92 0.33%
Depreciation 49.25 45.45 8.36% 48.45 43.98 10.16% 49.43 42.91 15.19% 46.62 40.38 15.45%
PBT 133.44 143.09 -6.74% 189.07 172.36 9.69% 181.10 170.60 6.15% 143.65 141.04 1.85%
Tax 32.06 15.74 103.68% 46.21 48.82 -5.35% 50.28 45.44 10.65% 37.39 39.03 -4.20%
PAT 101.38 127.35 -20.39% 142.86 123.54 15.64% 130.82 125.16 4.52% 106.26 102.01 4.17%
PATM 10.89% 15.75% 15.14% 14.84% 13.68% 14.83% 12.34% 13.20%
EPS 3.78 4.74 -20.25% 5.32 4.61 15.40% 4.87 4.66 4.51% 3.96 3.80 4.21%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 2,703.33 2,280.01 1,973.54 1,764.96 1,227.40 1,472.09 1,381.89 1,194.04 1,069.69 916.74 743.89 Net Sales Growth 19.35% 15.53% 11.82% 43.80% -16.62% 6.53% 15.73% 11.62% 16.68% 23.24% Cost Of Goods Sold 656.99 540.33 458.70 441.02 297.77 319.20 363.06 321.95 0.00 0.00 0.00 Gross Profit 2,046.34 1,739.67 1,514.83 1,323.94 929.63 1,152.88 1,018.84 872.09 1,069.69 916.74 743.89 GP Margin 75.70% 76.30% 76.76% 75.01% 75.74% 78.32% 73.73% 73.04% 100% 100% 100% Total Expenditure 2,086.00 1,776.65 1,551.52 1,384.17 1,054.48 1,253.59 1,076.91 930.86 851.47 743.81 573.20 Power & Fuel Cost - 35.86 36.84 31.80 27.43 31.11 29.22 26.68 0.00 0.00 0.00 % Of Sales - 1.57% 1.87% 1.80% 2.23% 2.11% 2.11% 2.23% 0% 0% 0% Employee Cost - 591.06 532.91 494.66 415.91 522.30 471.70 421.56 0.00 0.00 0.00 % Of Sales - 25.92% 27.00% 28.03% 33.89% 35.48% 34.13% 35.31% 0% 0% 0% Manufacturing Exp. - 346.11 305.30 261.87 178.72 133.30 25.75 22.98 0.00 0.00 0.00 % Of Sales - 15.18% 15.47% 14.84% 14.56% 9.06% 1.86% 1.92% 0% 0% 0% General & Admin Exp. - 227.35 202.27 143.99 119.08 231.18 96.56 72.81 851.47 743.81 573.20 % Of Sales - 9.97% 10.25% 8.16% 9.70% 15.70% 6.99% 6.10% 79.60% 81.14% 77.05% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 35.93 15.49 10.83 15.59 16.50 90.61 64.88 0.00 0.00 0.00 % Of Sales - 1.58% 0.78% 0.61% 1.27% 1.12% 6.56% 5.43% 0% 0% 0% EBITDA 617.33 503.36 422.02 380.79 172.92 218.50 304.98 263.18 218.22 172.93 170.69 EBITDA Margin 22.84% 22.08% 21.38% 21.57% 14.09% 14.84% 22.07% 22.04% 20.40% 18.86% 22.95% Other Income 98.12 102.87 47.59 35.04 28.35 43.54 45.40 36.33 33.51 25.33 15.12 Interest 24.36 30.46 31.82 32.83 29.20 32.54 14.29 8.92 0.00 0.00 56.14 Depreciation 109.63 87.09 86.09 87.17 87.64 98.57 68.53 61.74 46.77 45.63 43.57 PBT 531.55 488.67 351.71 295.83 84.42 130.93 267.57 228.86 204.96 152.63 86.10 Tax 138.09 127.78 88.46 77.04 27.14 28.18 91.93 79.35 71.59 49.49 5.83 Tax Rate 25.98% 26.15% 25.15% 26.04% 32.15% 21.52% 34.36% 34.67% 34.93% 32.42% 6.77% PAT 393.46 360.89 263.25 218.78 57.28 102.76 175.63 149.51 133.37 103.14 80.28 PAT before Minority Interest 393.46 360.89 263.25 218.78 57.28 102.76 175.63 149.51 133.37 103.14 80.28 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.55% 15.83% 13.34% 12.40% 4.67% 6.98% 12.71% 12.52% 12.47% 11.25% 10.79% PAT Growth 9.02% 37.09% 20.33% 281.95% -44.26% -41.49% 17.47% 12.10% 29.31% 28.48% EPS 14.65 13.44 9.80 8.15 2.13 3.83 6.54 5.57 4.97 3.84 2.99

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 16 Mar 15
Net Sales 3,692.32 3,275.11 2,709.88 2,167.30 1,446.74 1,500.42 1,382.05 1,194.25 Net Sales Growth 13.32% 20.86% 25.03% 49.81% -3.58% 8.56% 15.73% Cost Of Goods Sold 879.67 747.96 615.24 532.97 343.66 324.83 363.07 321.97 Gross Profit 2,812.65 2,527.16 2,094.63 1,634.32 1,103.09 1,175.59 1,018.98 872.28 GP Margin 76.18% 77.16% 77.30% 75.41% 76.25% 78.35% 73.73% 73.04% Total Expenditure 2,815.25 2,466.17 2,073.63 1,709.22 1,249.84 1,308.78 1,080.57 931.57 Power & Fuel Cost - 59.91 57.12 47.06 38.56 34.60 29.22 26.68 % Of Sales - 1.83% 2.11% 2.17% 2.67% 2.31% 2.11% 2.23% Employee Cost - 734.86 635.65 567.96 466.34 538.78 471.87 422.13 % Of Sales - 22.44% 23.46% 26.21% 32.23% 35.91% 34.14% 35.35% Manufacturing Exp. - 513.30 422.07 361.45 231.24 139.21 29.97 19.90 % Of Sales - 15.67% 15.58% 16.68% 15.98% 9.28% 2.17% 1.67% General & Admin Exp. - 301.31 266.49 185.54 146.23 252.56 101.94 74.75 % Of Sales - 9.20% 9.83% 8.56% 10.11% 16.83% 7.38% 6.26% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 108.84 77.06 14.24 23.82 18.80 84.50 66.14 % Of Sales - 3.32% 2.84% 0.66% 1.65% 1.25% 6.11% 5.54% EBITDA 877.06 808.94 636.25 458.08 196.90 191.64 301.48 262.68 EBITDA Margin 23.75% 24.70% 23.48% 21.14% 13.61% 12.77% 21.81% 22.00% Other Income 79.10 74.66 49.29 38.52 31.41 43.84 45.34 35.85 Interest 65.25 83.78 86.33 86.32 72.64 56.56 14.30 8.92 Depreciation 193.75 172.73 149.91 129.71 123.21 115.04 70.38 63.67 PBT 647.26 627.10 449.29 280.56 32.47 63.89 262.14 225.95 Tax 165.94 149.04 123.21 84.36 3.66 27.54 91.93 79.30 Tax Rate 25.64% 23.77% 27.42% 30.07% 11.27% 43.11% 35.07% 35.10% PAT 481.32 478.19 326.08 196.20 28.81 36.35 170.23 147.18 PAT before Minority Interest 481.44 478.06 326.08 196.20 28.81 36.35 170.21 146.65 Minority Interest 0.12 0.13 0.00 0.00 0.00 0.00 0.02 0.53 PAT Margin 13.04% 14.60% 12.03% 9.05% 1.99% 2.42% 12.32% 12.32% PAT Growth 0.68% 46.65% 66.20% 581.01% -20.74% -78.65% 15.66% EPS 17.92 17.80 12.14 7.30 1.07 1.35 6.34 5.48

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 2,848.80 2,488.86 1,739.75 1,483.63 1,422.72 Share Capital 53.70 53.64 50.64 82.09 81.84 Total Reserves 2,790.71 2,430.09 1,683.59 1,369.22 1,292.44 Non-Current Liabilities 958.08 868.88 811.89 666.27 324.45 Secured Loans 0.00 33.31 66.45 0.48 18.08 Unsecured Loans 0.00 24.67 22.27 18.87 0.00 Long Term Provisions 792.15 650.92 552.22 458.68 84.99 Current Liabilities 419.59 396.64 301.92 268.20 260.45 Trade Payables 137.80 142.33 103.28 109.21 118.04 Other Current Liabilities 251.45 234.32 185.07 136.93 126.89 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 30.34 19.99 13.58 22.06 15.53 Total Liabilities 4,226.47 3,754.38 2,853.56 2,418.10 2,007.62 Net Block 841.21 809.89 826.95 851.40 928.87 Gross Block 1,580.95 1,472.48 1,409.64 1,353.68 1,350.14 Accumulated Depreciation 739.74 662.59 582.69 502.27 421.27 Non Current Assets 2,935.91 2,356.47 2,137.46 1,962.82 1,571.85 Capital Work in Progress 184.09 74.94 6.42 4.16 3.47 Non Current Investment 790.10 764.99 734.02 625.55 500.50 Long Term Loans & Adv. 1,109.32 680.41 562.48 470.38 121.60 Other Non Current Assets 11.20 26.24 7.59 11.32 17.41 Current Assets 1,290.55 1,397.92 716.12 455.29 435.77 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 44.27 42.21 40.02 31.69 32.26 Sundry Debtors 191.87 173.09 173.05 129.84 148.42 Cash & Bank 959.21 1,144.82 441.33 254.77 218.77 Other Current Assets 95.21 15.15 43.59 23.86 36.32 Short Term Loans & Adv. 81.13 22.64 18.12 15.13 8.31 Net Current Assets 870.96 1,001.27 414.19 187.08 175.32 Total Assets 4,226.46 3,754.39 2,853.58 2,418.11 2,007.62

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 2,905.63 2,428.21 1,616.01 1,382.34 1,349.54 Share Capital 53.70 53.64 50.64 82.09 81.84 Total Reserves 2,847.54 2,369.43 1,559.84 1,267.93 1,219.26 Non-Current Liabilities 719.42 1,089.49 1,586.27 1,299.73 1,008.81 Secured Loans 235.96 659.47 717.17 551.43 605.52 Unsecured Loans 47.51 77.65 50.46 26.27 0.00 Long Term Provisions 57.74 54.04 555.12 460.70 85.81 Current Liabilities 617.73 572.55 419.48 404.66 357.66 Trade Payables 186.78 194.69 134.33 131.55 130.74 Other Current Liabilities 394.48 352.09 265.84 245.40 207.99 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 36.48 25.78 19.31 27.72 18.93 Total Liabilities 4,242.75 4,090.25 3,621.76 3,086.73 2,716.01 Net Block 2,235.91 2,050.09 1,775.86 1,615.67 1,703.11 Gross Block 3,227.02 2,877.28 2,457.99 2,172.59 2,140.90 Accumulated Depreciation 991.11 827.19 682.13 556.92 437.79 Non Current Assets 2,734.02 2,510.77 2,810.03 2,584.60 2,237.41 Capital Work in Progress 387.54 326.98 439.25 463.82 381.73 Non Current Investment 0.05 0.05 0.05 0.05 0.00 Long Term Loans & Adv. 92.87 99.61 583.22 485.93 128.04 Other Non Current Assets 17.65 34.05 11.64 19.13 24.53 Current Assets 1,508.73 1,579.49 811.73 502.13 478.60 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 66.85 60.37 53.39 39.76 38.52 Sundry Debtors 215.31 194.20 180.20 133.63 149.15 Cash & Bank 1,175.28 1,278.10 511.81 289.30 250.12 Other Current Assets 51.29 18.99 46.10 23.40 40.80 Short Term Loans & Adv. 34.11 27.82 20.23 16.05 8.60 Net Current Assets 891.00 1,006.93 392.24 97.47 120.93 Total Assets 4,242.75 4,090.26 3,621.76 3,086.73 2,716.01

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 340.64 430.53 235.40 200.88 192.56 PBT 488.67 351.71 295.83 84.42 130.93 Adjustment 53.02 83.30 99.85 104.94 121.74 Changes in Working Capital -56.37 96.47 -69.49 26.16 -3.95 Cash after chg. in Working capital 485.33 531.48 326.18 215.52 248.72 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -144.69 -100.95 -90.78 -14.63 -56.16 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -698.52 -257.29 -312.99 -250.46 -45.34 Net Fixed Assets -217.62 -131.36 -58.22 -4.23 Net Investments -25.11 -30.97 -108.47 -125.05 Others -455.79 -94.96 -146.30 -121.18 Cash from Financing Activity -66.23 404.22 97.59 -36.67 -55.64 Net Cash Inflow / Outflow -424.11 577.47 20.01 -86.25 91.58 Opening Cash & Equivalents 642.78 65.31 45.31 131.55 39.98 Closing Cash & Equivalent 218.67 642.78 65.31 45.31 131.55

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 612.08 644.52 311.26 241.77 175.07 PBT 627.10 449.29 280.56 32.46 63.89 Adjustment 215.58 198.55 195.49 189.11 165.28 Changes in Working Capital -53.13 102.82 -66.77 36.59 2.07 Cash after chg. in Working capital 789.55 750.66 409.28 258.17 231.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -177.46 -106.14 -98.02 -16.40 -56.18 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -440.80 -342.35 -420.88 -239.15 -87.07 Net Fixed Assets -217.62 -131.36 -58.22 -4.23 Net Investments -25.11 -30.97 -108.47 -125.05 Others -198.07 -180.02 -254.19 -109.87 Cash from Financing Activity -513.92 345.64 159.59 -80.72 -0.88 Net Cash Inflow / Outflow -342.63 647.81 49.97 -78.11 87.12 Opening Cash & Equivalents 767.24 119.43 69.47 147.57 60.45 Closing Cash & Equivalent 424.61 767.24 119.43 69.47 147.57

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 105.94 92.61 68.49 57.23 271.92 ROA 9.04% 7.97% 8.30% 2.59% 5.46% ROE 13.55% 12.48% 13.88% 4.15% 8.00% ROCE 18.88% 17.23% 19.51% 7.69% 11.30% Fixed Asset Turnover 1.49 1.37 1.28 0.91 1.16 Receivable days 29.21 32.01 31.32 41.37 38.75 Inventory Days 6.92 7.60 7.41 9.51 6.89 Payable days 94.61 97.72 87.93 139.28 39.99 Cash Conversion Cycle -58.48 -58.10 -49.20 -88.40 5.65 Total Debt/Equity 0.02 0.04 0.07 0.02 0.02 Interest Cover 17.04 12.05 10.01 3.89 5.02

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 108.05 90.35 63.60 53.14 257.09 ROA 11.47% 8.46% 5.85% 0.99% 1.46% ROE 17.96% 16.17% 13.40% 2.23% 2.92% ROCE 21.56% 18.71% 16.38% 5.26% 6.20% Fixed Asset Turnover 1.07 1.02 0.94 0.67 0.86 Receivable days 22.82 25.21 26.43 35.67 38.11 Inventory Days 7.09 7.66 7.84 9.87 7.52 Payable days 93.08 97.60 91.04 139.29 40.14 Cash Conversion Cycle -63.17 -64.72 -56.77 -93.75 5.49 Total Debt/Equity 0.14 0.35 0.52 0.48 0.48 Interest Cover 8.48 6.20 4.25 1.45 2.13

Top Investors:

dunearn investments (mauritius) pte ltd

sunil sachdeva

rj corp limited

government pension fund global

kotak india eq contra fund

invesco india aggressive hybrid fund

polaris healthcare investments pte ltd

canara robeco mutual fund a/c canara robeco emergi

uti-flexi cap fund

novo holdings a/s

Annual Reports:

News Update:

Global Health gets board’s nod to purchase land parcel in Assam
28th Apr 2025, 16:13 PM

The proposed capacity will be added over the next 3-4 years in a phased manner
Read More
Global Health gets offer from AEGCL to acquire land parcel
8th Apr 2025, 14:09 PM

The company has received an offer to acquire 3-acre land parcel for purpose of setting up a super speciality hospital in Guwahati
Read More

Global Health Ltd.

Hospital & Healthcare Services

BSE: 543654 | NSE: MEDANTA

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Global Health Ltd.

Hospital & Healthcare Services

BSE: 543654 | NSE: MEDANTA

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: